The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 41, 2008, Pages 15690-15695

  Sadeh, Ronen ^a   Breitschopf, Kristin ^a,c   Bercovich, Beatrice ^a   Zoabi, Muhammad ^a   Kravtsova Ivantsiv, Yelena ^a   Kornitzer, Daniel ^a   Schwartz, Alan ^b   Ciechanover, Aaron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LYSINE; MYOD PROTEIN; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL NUCLEUS; MOLECULAR EVOLUTION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STABILITY; SACCHAROMYCES CEREVISIAE; UBIQUITINATION;

ANIMALS; CELL NUCLEUS; CONSERVED SEQUENCE; LYSINE; MICE; MYOD PROTEIN; PROTEIN STRUCTURE, TERTIARY; UBIQUITIN;

SACCHAROMYCES CEREVISIAE;

EID: 57349123491     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0808373105     Document Type: Article

References (36)

1. Ciechanover A, Ben-Saadon R (2004) N-terminal ubiquitination: More protein substrates join in. Trends Cell Biol 14:103-106.
2. Cadwell K, Coscoy L (2005) Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309:127-130.
3. Tait SW, et al. (2007) Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J Cell Biol 179:1453-1466.
4. Wang X, et al. (2007) Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J Cell Biol 177:613-624.
5. Breitschopf K, Bengal E, Ziv T, Admon A, Ciechanover A (1998) A novel site for ubiquitination: The N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J 17:5964-5973.
6. Aviel S, Winberg G, Massucci M, Ciechanover A (2000) Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. J Biol Chem 275:23491-23499.
7. Ikeda M, Ikeda A, Longnecker R (2002) Lysine-independent ubiquitination of Epstein-Barr virus LMP2A. Virology 300:153-159.
8. Reinstein E, Scheffner M, Oren M, Ciechanover A, Schwartz A (2000) Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: Targeting via ubiquitination of the N-terminal residue. Oncogene 19:5944-5950.
9. Fajerman I, Schwartz AL, Ciechanover A (2004) Degradation of the Id2 developmental regulator: Targeting via N-terminal ubiquitination. Biochem Biophys Res Commun 314:505-512.
10. Ben-Saadon R, et al. (2004) The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue. J Biol Chem 279:41414-41421.
11. Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ (2004) N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev 18:1862-1874.
12. Bachmair A, Finley D, Varshavsky A (1986) In vivo half-life of a protein is a function of its amino-terminal residue. Science 234:179-186.
13. Tasaki T, Kwon YT (2007) The mammalian N-end rule pathway: New insights into its components and physiological roles. Trends Biochem Sci 32:520-528.
14. Abu Hatoum O, et al. (1998) Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: Regulation by specific DNA binding. Mol Cell Biol 18:5670-5677.
15. Batonnet-Pichon S, et al. (2006) MyoD undergoes a distinct G2/M-specific regulation in muscle cells. Exp Cell Res 312:3999-4010.
16. Song A, Wang Q, Goebl MG, Harrington MA (1998) Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol 18:4994-4999.
17. Kelly SM, Vanslyke JK, Musil LS (2007) Regulation of ubiquitin-proteasome system mediated degradation by cytosolic stress. Mol Biol Cell 18:4279-4291.
18. Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL (2003) Determinants of nuclear and cytoplasmic ubiquitin-mediated degradation of MyoD. J Biol Chem 278:1817-1823.
19. Floyd ZE, Trausch-Azar JS, Reinstein E, Ciechanover A, Schwartz AL (2001) The nuclear ubiquitin-proteasome system degrades MyoD. J Biol Chem 276:22468-22475.
20. Batonnet S, Leibovitch MP, Tintignac L, Leibovitch SA (2004) Critical role for lysine 133 in the nuclear ubiquitin-mediated degradation of MyoD. J Biol Chem 279:5413-5420.
21. Kalderon D, Roberts BL, Richardson WD, Smith AE (1984) A short amino acid sequence able to specify nuclear location. Cell 39:499-509.
22. Lanford RE, Butel JS (1984) Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell 37:801-813.
23. Sheaff RJ, et al. (2000) Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 5:403-410.
24. Johnson ES, Ma PC, Ota IM, Varshavsky A (1995) A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem 270:17442-17456.
25. Spence J, Sadis S, Haas AL, Finley D (1995) A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol 15:1265-1273.
26. Finley D, et al. (1994) Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol Cell Biol 14:5501-5509.
27. Sears C, Olesen J, Rubin D, Finley D, Maniatis T (1998) NF-kappa B p105 processing via the ubiquitin-proteasome pathway. J Biol Chem 273:1409-1419.
28. Lai Z, et al. (2001) Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization. J Biol Chem 276:31357-31367.
29. Tomoda K, Kubota Y, Kato J (1999) Degradation of the cyclin-dependent- kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398:160-165.
30. Henderson BR (2000) Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2:653-660.
31. Inobe T, Matouschek A (2008) Protein targeting to ATP-dependent proteases. Curr Opin Struct Biol 18:43-51.
32. Lee C, Schwartz MP, Prakash S, Iwakura M, Matouschek A (2001) ATP-dependent proteases degrade their substrates by processively unraveling them from the degradation signal. Mol Cell 7:627-637.
33. Kurowski MA, Bujnicki JM (2003) GeneSilico protein structure prediction meta-server. Nucleic Acids Res 31:3305-3307.
34. Bennett-Lovsey RM, Herbert AD, Sternberg MJ, Kelley LA (2008) Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre. Proteins 70:611-625.
35. Ferron F, Longhi S, Canard B, Karlin D (2006) A practical overview of protein disorder prediction methods. Proteins 65:1-14.
36. Heessen S, et al. (2002) Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis. Proc Natl Acad Sci USA 99:1532-1537.